 <h1>Mycophenolate mofetil Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of mycophenolate mofetil include:</b> asthma, herpes simplex infection, infection, metabolic acidosis, oral candidiasis, pleural effusion, respiratory tract infection, systemic cytomegalovirus disease, urinary tract infection, viremia, abdominal pain, acne vulgaris, anemia, anxiety, asthenia, back pain, cardiovascular disorder, chest pain, constipation, cough, depression, diarrhea, disorder of integument, drowsiness, dyspepsia, dyspnea, edema, fever, headache, hypercholesterolemia, hyperlipidemia, hypertension, hypertonia, hyperuricemia, hypervolemia, hypokalemia, hypotension, increased lactate dehydrogenase, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, increased serum creatinine, leukopenia, lower limb cramp, myalgia, myasthenia, nausea, pain, paresthesia, peripheral edema, pulmonary disease, rhinitis, sinusitis, tachycardia, thrombocytopenia, tremor, vomiting, weight gain, chills, and flatulence. <b>Other side effects include:</b> malignant neoplasm of skin, dizziness, and insomnia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to mycophenolate mofetil: oral capsule, oral powder for suspension, oral tablet</i></p><p>Other dosage forms:</p><ul><li>intravenous powder for solution</li></ul><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Capsule; Tablet; Powder for Suspension)</p><p>Embryofetal Toxicity, Malignancies and Serious InfectionsUse during pregnancy is associated with increased risks of first trimester pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning.Increased risk of development of lymphoma and other malignancies, particularly of the skin.Increased susceptibility to infections, including opportunistic infections and severe infections with fatal outcomes.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, mycophenolate mofetil may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking mycophenolate mofetil:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach cramps or pain</li>
<li>black, tarry stools</li>
<li>bladder pain</li>
<li>bleeding gums</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>blood in the urine or stools</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>chest pain</li>
<li>confusion</li>
<li>convulsions</li>
<li>cough or hoarseness</li>
<li>decreased urine</li>
<li>difficult or labored breathing</li>
<li>difficult, burning, or painful urination</li>
<li>dizziness</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>drowsiness</li>
<li>dry mouth</li>
<li>fainting</li>
<li>fast, slow, pounding, or irregular heartbeat or pulse</li>
<li>fever or chills</li>
<li>flushed, dry skin</li>
<li>frequent urge to urinate</li>
<li>fruit-like breath odor</li>
<li>headache</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>irregular heartbeats</li>
<li>irregular pulse</li>
<li>irritability</li>
<li>lightheadedness</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>muscle cramps in the hands, arms, feet, legs, or face</li>
<li>muscle pain or cramps</li>
<li>muscle spasms (tetany) or twitching</li>
<li>nausea or vomiting</li>
<li>nervousness</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>pounding in the ears</li>
<li>rapid weight gain</li>
<li>rapid, shallow breathing</li>
<li>seizures</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stomach pain and bloating</li>
<li>sweating</li>
<li>swollen glands</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>trembling</li>
<li>tremor</li>
<li>troubled breathing with exertion</li>
<li>unexplained weight loss</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
<li>weakness or heaviness of the legs</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Back pain</li>
<li>constipation</li>
<li>coughing or spitting up blood</li>
<li>darkened urine</li>
<li>general feeling of illness</li>
<li>indigestion</li>
<li>night sweats</li>
<li>pain</li>
<li>pains in the stomach, side, or abdomen, possibly radiating to the back</li>
<li>severe headache</li>
<li>sudden high fever or low-grade fever for months</li>
<li>tenderness</li>
<li>watery or bloody diarrhea</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of mycophenolate mofetil may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>fear</li>
<li>heartburn</li>
<li>lack or loss of strength</li>
<li>rash</li>
<li>trouble sleeping</li>
<li>weight loss</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to mycophenolate mofetil: intravenous powder for injection, oral capsule, oral powder for reconstitution, oral tablet</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (36%), nausea (20%), vomiting (13%), abdominal pain</p>
<p><b>Common</b> (1% to 10%): GI infection, gastroenteritis</p>
<p><b>Rare</b> (less than 0.1%): Gingival hyperplasia, colitis including cytomegalovirus colitis, pancreatitis intestinal villous atrophy</p>
<p><b>Frequency not reported</b>: Ischemic colitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Leukopenia (11% to 35%), anemia (35%)</p>
<p><b>Common</b> (1% to 10%): Blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, blood alkaline phosphatase increased, thrombocytopenia, neutropenia</p>
<p><b>Very rare</b> (less than 0.01%): Deep venous thrombosis</p>
<p><b>Postmarketing reports</b>: Pure red cell aplasia (PRCA), abnormal neutrophil morphology, including the acquired Pelger-Huet anomaly<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Sepsis (primarily cytomegalovirus viremia) (20%), gastrointestinal candidiasis, urinary tract infection, herpes simplex, herpes zoster</p>
<p><b>Common</b> (1% to 10%): Pneumonia, influenza, respiratory tract infection, respiratory moniliasis, gastrointestinal infection, candidiasis, gastroenteritis, infection, bronchitis, pharyngitis, sinusitis, fungal skin infection, skin candida, vaginal candidiasis</p>
<p><b>Postmarketing reports</b>: Hypogammaglobulinemia Serious life-threatening infections including meningitis, endocarditis, tuberculosis, atypical mycobacterial infection<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Lymphoma, lymphoproliferative disease, non-melanoma skin carcinoma<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Hematuria (13%), kidney tubular necrosis (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Renal impairment</p>
<p><b>Frequency not reported</b>: BK virus-associated nephropathy<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Edema (12% to 28%), hyperphosphatemia (13%), hypokalemia (10%), hyperglycemia (10%)</p>
<p><b>Common</b> (1% to 10%): Weight loss, hyperkalemia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Respiratory tract infection (23%), dyspnea (16%), increased cough (16%) </p>
<p><b>Common</b> (1% to 10%): Pneumonia, respiratory moniliasis, bronchitis, pharyngitis, sinusitis, rhinitis, pleural effusion<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Fungal skin infection, skin hypertrophy, rash, acne, alopecia </p>
<p><b>Very rare</b> (less than 0.01%): Dyshidrotic eczema, papulosquamous psoriatic-like skin eruption<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia</p>
<p><b>Very rare</b> (less than 0.01%): Myopathy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Edema, pyrexia, chills, pain, malaise, asthenia</p>
<p><b>Frequency not reported</b>: Congenital malformations, increased incidence of first trimester pregnancy loss<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Hepatitis, jaundice, hyperbilirubinemia, hepatic enzyme increased</p>
<p><b>Very rare</b> (less than 0.01%): Sodium-induced hepatotoxicity<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia, hypotension, hypertension, vasodilatation</p>
<p><b>Postmarketing reports</b>: Endocarditis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection (up to 45%), vaginal candidiasis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Angioneurotic edema, anaphylactic reaction<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. CellCept (mycophenolate mofetil)." Roche Laboratories, Nutley, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about mycophenolate mofetil</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>50 Reviews</li>
<li>Drug class: selective immunosuppressants</li>
<li>FDA Alerts (3)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Mycophenolate Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Mycophenolate mofetil &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>CellCept</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +6 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Autoimmune Hepatitis</li>
<li>Crohn's Disease</li>
<li>Bullous Pemphigoid</li>
<li>Cogan's Syndrome</li>
<li data-more-config-id="list-data-resources-conditions">... +19 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to mycophenolate mofetil: intravenous powder for injection, oral capsule, oral powder for reconstitution, oral tablet</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (36%), nausea (20%), vomiting (13%), abdominal pain</p><p><b>Common</b> (1% to 10%): GI infection, gastroenteritis</p><p><b>Rare</b> (less than 0.1%): Gingival hyperplasia, colitis including cytomegalovirus colitis, pancreatitis intestinal villous atrophy</p><p><b>Frequency not reported</b>: Ischemic colitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Leukopenia (11% to 35%), anemia (35%)</p><p><b>Common</b> (1% to 10%): Blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, blood alkaline phosphatase increased, thrombocytopenia, neutropenia</p><p><b>Very rare</b> (less than 0.01%): Deep venous thrombosis</p><p><b>Postmarketing reports</b>: Pure red cell aplasia (PRCA), abnormal neutrophil morphology, including the acquired Pelger-Huet anomaly<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Sepsis (primarily cytomegalovirus viremia) (20%), gastrointestinal candidiasis, urinary tract infection, herpes simplex, herpes zoster</p><p><b>Common</b> (1% to 10%): Pneumonia, influenza, respiratory tract infection, respiratory moniliasis, gastrointestinal infection, candidiasis, gastroenteritis, infection, bronchitis, pharyngitis, sinusitis, fungal skin infection, skin candida, vaginal candidiasis</p><p><b>Postmarketing reports</b>: Hypogammaglobulinemia Serious life-threatening infections including meningitis, endocarditis, tuberculosis, atypical mycobacterial infection<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Lymphoma, lymphoproliferative disease, non-melanoma skin carcinoma<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Hematuria (13%), kidney tubular necrosis (up to 10%)</p><p><b>Common</b> (1% to 10%): Renal impairment</p><p><b>Frequency not reported</b>: BK virus-associated nephropathy<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Edema (12% to 28%), hyperphosphatemia (13%), hypokalemia (10%), hyperglycemia (10%)</p><p><b>Common</b> (1% to 10%): Weight loss, hyperkalemia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Respiratory tract infection (23%), dyspnea (16%), increased cough (16%) </p><p><b>Common</b> (1% to 10%): Pneumonia, respiratory moniliasis, bronchitis, pharyngitis, sinusitis, rhinitis, pleural effusion<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Fungal skin infection, skin hypertrophy, rash, acne, alopecia </p><p><b>Very rare</b> (less than 0.01%): Dyshidrotic eczema, papulosquamous psoriatic-like skin eruption<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia</p><p><b>Very rare</b> (less than 0.01%): Myopathy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Edema, pyrexia, chills, pain, malaise, asthenia</p><p><b>Frequency not reported</b>: Congenital malformations, increased incidence of first trimester pregnancy loss<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Hepatitis, jaundice, hyperbilirubinemia, hepatic enzyme increased</p><p><b>Very rare</b> (less than 0.01%): Sodium-induced hepatotoxicity<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia, hypotension, hypertension, vasodilatation</p><p><b>Postmarketing reports</b>: Endocarditis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection (up to 45%), vaginal candidiasis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Angioneurotic edema, anaphylactic reaction<sup>[Ref]</sup></p><p id="ref_1">1. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. CellCept (mycophenolate mofetil)." Roche Laboratories, Nutley, NJ. </p><h2>More about mycophenolate mofetil</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>50 Reviews</li>
<li>Drug class: selective immunosuppressants</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Mycophenolate Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Mycophenolate mofetil &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +6 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Autoimmune Hepatitis</li>
<li>Crohn's Disease</li>
<li>Bullous Pemphigoid</li>
<li>Cogan's Syndrome</li>
<li data-more-config-id="list-data-resources-conditions">... +19 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>